F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance
The <i>FBXO22</i> gene is a biomarker of poor prognosis in patients with colon cancer and has potential as a target for immunotherapy and overcoming chemotherapy resistance.
Authors
- Yong-Ze Guo
- Xiao Chang (ORCID: https://orcid.org/0000-0003-0560-2441)
- Xiaofei Lü (ORCID: https://orcid.org/0000-0002-3293-8314)
- Hong-Wei Zhang (ORCID: https://orcid.org/0000-0001-7508-5553)
Institutions
- Hebei University of Engineering (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.4251/wjgo.v17.i4.102913
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00